CSIR Central

AVCpred: an integrated web server for prediction and design of antiviral compounds

IR@IMTECH: CSIR-Institute of Microbial Technology, Chandigarh

View Archive Info
 
 
Field Value
 
Title AVCpred: an integrated web server for prediction and design of antiviral compounds
 
Creator Qureshi, Abid
Kaur, Gazaldeep
Kumar, Manoj
 
Subject QR Microbiology
 
Description iral infections constantly jeopardize the global public health due to lack of effective antiviral therapeutics. Therefore, there is an imperative need to speed up the drug discovery process to identify novel and efficient drug candidates. In this study, we have developed quantitative structure–activity relationship (QSAR)‐based models for predicting antiviral compounds (AVCs) against deadly viruses like human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), human herpesvirus (HHV) and 26 others using publicly available experimental data from the ChEMBL bioactivity database. Support vector machine (SVM) models achieved a maximum Pearson correlation coefficient of 0.72, 0.74, 0.66, 0.68, and 0.71 in regression mode and a maximum Matthew's correlation coefficient 0.91, 0.93, 0.70, 0.89, and 0.71, respectively, in classification mode during 10‐fold cross‐validation. Furthermore, similar performance was observed on the independent validation sets. We have integrated these models in the AVCpred web server, freely available at http://crdd.osdd.net/servers/avcpred. In addition, the datasets are provided in a searchable format. We hope this web server will assist researchers in the identification of potential antiviral agents. It would also save time and cost by prioritizing new drugs against viruses before their synthesis and experimental testing.
 
Publisher Wiley
 
Date 2016
 
Type Article
PeerReviewed
 
Relation http://dx.doi.org/10.1111/cbdd.12834
http://crdd.osdd.net/open/1987/
 
Identifier Qureshi, Abid and Kaur, Gazaldeep and Kumar, Manoj (2016) AVCpred: an integrated web server for prediction and design of antiviral compounds. Chemical Biology & Drug Design, 89 (1). pp. 74-83. ISSN 17470277